Nanexa
1,51
SEK
+3,42 %
NANEXA
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Mindre end 1K følgere
+3,42%
-36,29%
-30,09%
+2,37%
+53,77%
+41,12%
-62,72%
-79,94%
-81,54%
Nanexa is a drug delivery company with a proprietary platform that is used for the formulation of injectable depot drugs that create a supply of drugs to the blood. The PharmaShell process is based on ALD (Atomic Layer Deposition) technology, which encloses pharmaceutical particles with a thin shell and creates opportunities for pharmaceutical companies to develop new products. Nanexa has cooperation with several pharmaceutical companies, mainly around the Nordic market.
Læs mereMarkedsværdi
225,29 mio. SEK
Aktieomsætning
324,42 t SEK
Omsætning
29,33 mio.
EBIT %
-261,27 %
P/E
-
Udbytteafkast, %
-
Finanskalender
13.2
2025
Ekstraordinær generalforsamling '24
19.2
2025
Årsrapport '24
ViserAlle indholdstyper
Emergers: Equity Research | NANEXA: Financing secured into 2026 to drive NEX-22 development
Notice of extraordinary general meeting in Nanexa AB
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools